Caracterización de la enfermedad de Kawasaki en niños entre 3 meses y 15 años en 2 instituciones de salud en Bogotá, Colombia
Objective: To reduce the knowledge gap about Kawasaki Disease (KD) and to provide tools to medical personnel through the description of demographics, clinical presentation, laboratory findings, frequency of coronary lesions and outcomes in 2 health institutions in Bogota Colombia.Methodology: Retrospective observational study by reviewing the clinical records of the ICD-10 codes of pediatric patients where demographic characteristics, clinical presentation, paraclinical data (including echocardiographic findings), treatment received and response to it were evaluated, in patients admitted between June 2015 and June 2020.Results: The mean age of the patients was 2.9 years, being KD more frequent in boys a 2:1 ratio. 61.1% had complete or classic KD, 30.5% had incomplete KD, and 8.3% atypical KD. All patients received intravenous immunoglobulin before day 10 of the course of the disease, with remission of fever within 12 hours after administration. The incidence of coronary compromise was 30.6%.Conclusions: KD has a characteristic clinical course that especially affects children under 5 years. A more frequent recognition of this clinical entity by pediatricians, allows for an early diagnosis and treatment avoiding complications and sequelae in the medium and long term..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
|---|---|
| Enthalten in: |
Infectio - 26(2021), 1, Seite 19-23 |
| Sprache: |
Englisch ; Spanisch |
|---|
| Beteiligte Personen: |
Paula Araque [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Coronary lesions |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
DOAJ023503092 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ023503092 | ||
| 003 | DE-627 | ||
| 005 | 20230307064818.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230226s2021 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)DOAJ023503092 | ||
| 035 | |a (DE-599)DOAJ5b7f422bafb8462fa86300a5ab0e1574 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a spa | ||
| 050 | 0 | |a RM1-950 | |
| 050 | 0 | |a RC109-216 | |
| 100 | 0 | |a Paula Araque |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Caracterización de la enfermedad de Kawasaki en niños entre 3 meses y 15 años en 2 instituciones de salud en Bogotá, Colombia |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Objective: To reduce the knowledge gap about Kawasaki Disease (KD) and to provide tools to medical personnel through the description of demographics, clinical presentation, laboratory findings, frequency of coronary lesions and outcomes in 2 health institutions in Bogota Colombia.Methodology: Retrospective observational study by reviewing the clinical records of the ICD-10 codes of pediatric patients where demographic characteristics, clinical presentation, paraclinical data (including echocardiographic findings), treatment received and response to it were evaluated, in patients admitted between June 2015 and June 2020.Results: The mean age of the patients was 2.9 years, being KD more frequent in boys a 2:1 ratio. 61.1% had complete or classic KD, 30.5% had incomplete KD, and 8.3% atypical KD. All patients received intravenous immunoglobulin before day 10 of the course of the disease, with remission of fever within 12 hours after administration. The incidence of coronary compromise was 30.6%.Conclusions: KD has a characteristic clinical course that especially affects children under 5 years. A more frequent recognition of this clinical entity by pediatricians, allows for an early diagnosis and treatment avoiding complications and sequelae in the medium and long term. | ||
| 650 | 4 | |a kawasaki disease | |
| 650 | 4 | |a coronary lesions | |
| 650 | 4 | |a latin america. | |
| 653 | 0 | |a Therapeutics. Pharmacology | |
| 653 | 0 | |a Infectious and parasitic diseases | |
| 773 | 0 | 8 | |i In |t Infectio |d Asociación Colombiana de Infectología, 2018 |g 26(2021), 1, Seite 19-23 |w (DE-627)DOAJ000064378 |x 01239392 |7 nnns |
| 773 | 1 | 8 | |g volume:26 |g year:2021 |g number:1 |g pages:19-23 |
| 856 | 4 | 0 | |u https://doi.org/10.22354/in.v26i1.989 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/5b7f422bafb8462fa86300a5ab0e1574 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/0123-9392 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 26 |j 2021 |e 1 |h 19-23 | ||